Orjaleza, Aidyn Gwynn S.
HRN: 25-84-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2024
CEFTRIAXONE 1G (VIAL)
11/18/2024
11/25/2024
IV
600mg
Q24H
PCAP C
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes